A Phase 3 Noninferiority Study Comparing the Efficacy, Immunogenicity, and Safety of Foligraf®: A Biosimilar Recombinant Human Follicle-stimulating Hormone and Gonal-f® (Prefilled Pen) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive Technology

Category Primary study
JournalInternational Journal of Infertility and Fetal Medicine
Year 2025
This article has no abstract
Epistemonikos ID: e3a457e4f91f5c8c9682202141e8827a25eadfbf
First added on: Jan 10, 2026